Wordt geladen...
Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study
BACKGROUND: A subset of critically ill COVID-19 patients develop a hyperinflammatory state. Anakinra, a recombinant interleukin-1 receptor antagonist, is known to be effective in several hyperinflammatory diseases. We investigated the effects of anakinra on inflammatory parameters and clinical outco...
Bewaard in:
| Gepubliceerd in: | Crit Care |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7726611/ https://ncbi.nlm.nih.gov/pubmed/33302991 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-020-03364-w |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|